Intravacc, the Institute for Translational Vaccinology, is an experienced, not-for-profit R&D organization with 100+ years’ experience in vaccine development. We optimize vaccines, vaccine processes and vaccine technologies. Our in-house expertise enables us to bridge the gap between fundamental research and advanced clinical studies in man. In our state-of-the-art (BSL2, BSL3 and GMP) facilities in Bilthoven, the Netherlands, our dedicated team takes your discovery up to Phase I/II clinical trials.
We offer tailor-made solutions for our clientele of Biotech, Big Pharma, Universities, Public Health institutes and Governments. Moreover, we share and transfer knowledge and technologies to public and private partners. Our aim is to substantially reduce development risks and costs of new vaccines in order to contribute to global health and equity in access to vaccines worldwide.